Johnson & Johnson (JNJ) revenue was $94.2B in FY2025 (+6% YoY). The tables below show the complete quarterly and annual revenue history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Revenue
Fiscal Year
Revenue
YoY
2025
$94.2B
+6%
2024
$88.8B
+4%
2023
$85.2B
+8%
2022
$78.7B
-5%
2021
$82.6B
+1%
2019
$82.1B
+1%
2018
$81.6B
+7%
2017
$76.5B
+9%
2016
$70.1B
-6%
2014
$74.3B
+4%
2013
$71.3B
+6%
2012
$67.2B
+9%
2011
$61.6B
-1%
2010
$61.9B
-3%
2008
$63.7B
+4%
2007
$61.1B
Recent Quarterly Revenue
Quarter
Revenue
Q2 2026
$25.3B
Q1 2026
$24.1B
Q4 2025
$24.6B
Q3 2025
$24.0B
Q2 2025
$23.7B
Q1 2025
$21.9B
Q4 2024
$22.5B
Q3 2024
$22.5B
Q2 2024
$22.4B
Q1 2024
$21.4B
Q4 2023
$21.4B
Q3 2023
$21.4B
Source: JNJ on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.